Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Good and Bad for Business

<< Previous

Bullboard Posts

Next >>

Comment by fasttrack5on Dec 18, 2023 5:44pm

85 Views

Post# 35790730

RE:Good and Bad for Business

Journeytc wrote: Cancer markets may climb dramatically. I think we're are on the verge of a cancer explosion with covi-Vax induced emergence of the IGG4 and its impact on CD4 etc. Hope I'm out to lunch. Insults accepted.

No insults Just take your conspiracy theory elsewhere.
just sayin:)

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles